's America's Greatest Workplaces in Health Care 2025
Prime Healthcare has been named one of America's Greatest Workplaces 2025 by Newsweek, recognizing its commitment to employee well-being, inclusion, and a workplace culture built on compassion, accountability, and service to others.
Share
Newsweek 's annual ranking commends companies that demonstrate a clear commitment to employee engagement and satisfaction.
'In the healthcare industry especially, organizations that invest in employee well-being are better positioned to meet the needs of their communities,' Jennifer H. Cunningham, Editor-in-Chief of Newsweek said. 'This year's honorees represent workplaces where employees feel supported, heard and valued.'
Prime Healthcare operates 51 hospitals and more than 360 outpatient locations across 14 states, serving more than 2.5 million patients annually. As one of the nation's leading health systems, Prime is recognized for its focus on clinical quality, patient safety, health equity and community-based care, reflecting its mission to save and improve hospitals through measurable results.
In addition to its national and healthcare recognitions, Prime Healthcare was also honored by Newsweek in several key categories in 2025, including:
Inclusion & Diversity
Women
Mental Wellbeing
Black Americans
Parents & Families
These distinctions highlight Prime's efforts to create an inclusive environment where individuals from all backgrounds feel valued and supported.
'At Prime, we believe great healthcare begins at the local level, and that the strength of our workforce plays a direct role in delivering quality, compassionate care,' said Sunny Bhatia, MD, President and Chief Medical Officer of Prime Healthcare. 'This recognition affirms our focus on cultivating a supportive environment for all employees, including our nurses, physicians and frontline staff.'
Prime's commitment to diversity, equity and inclusion is part of a broader effort to improve the well-being of employees and the communities it serves. The organization's approach to addressing social determinants of health has been recognized by The Joint Commission and the National Quality Forum for advancing health outcomes through systemwide collaboration.
In 2025, Prime Healthcare hospitals earned more than 150 clinical quality awards from Healthgrades, including more Patient Safety Excellence Awards than any other health system for the eighth consecutive year. Prime hospitals have also been named among Premier's '100 Top Hospitals' 72 times and recognized by the Lown Institute for achievements in health equity, patient outcomes and value of care.
About Prime Healthcare and Prime Healthcare Foundation
Prime Healthcare is an award-winning health system operating 51 hospitals and more than 360 outpatient locations in 14 states, providing over 2.5 million patient visits annually. It is one of the nation's leading health systems, with nearly 57,000 employees and physicians. Eighteen of the Prime Healthcare hospitals are members of the Prime Healthcare Foundation, a 501(c)(3) not-for-profit public charity. Based in Ontario, California, Prime Healthcare is nationally recognized for award-winning quality care and has been named a 10 Top and 15 Top Health System by Truven Health Analytics. Its hospitals have been named among the nation's '100 Top Hospitals' 72 times and it is one of Healthgrades' most awarded health systems in the nation for patient safety. To learn more, please visit primehealthcare.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Newsweek
3 hours ago
- Newsweek
Ozempic Is Costing Grocery Stores Billions
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. GLP-1 medications, including Ozempic and Mounjaro, are already costing grocery stores billions. According to a new report from Big Chalk Analytics, GLP-1 users have cut $6.5 billion from U.S. grocery spending, and the popularity of the weight loss and diabetes medications appears to only be growing. Why It Matters The use of weight-loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists has skyrocketed in recent years. Popular products include Ozempic, Mounjaro, Wegovy and Zepound and have been key treatments for many Americans who are obese or have type 2 diabetes. While the full health effects of these drugs in the long term has not been studied, their prevalence has shown the potential to disrupt industries by lowering grocery and even restaurant profits in the long term. People shop at a grocery store in Brooklyn on May 13, 2025 in New York City. People shop at a grocery store in Brooklyn on May 13, 2025 in New York To Know While GLP-1 medications are already reportedly costing grocers $6.5 billion, the impact could be even costlier in the years to come as 8.3 percent of Americans are planning to start the medications, according to the new Big Chalk survey of more than 4,500 consumers. If this happens, the survey projects losses as much as an additional $4.4 to $10.8 billion. "The changes being seen in grocery stores are the result of people making better choices about food –less ultra-processed food and possibly less food overall," David Navazio, CEO of health care product company Gentell, told Newsweek. Several types of products have seen their purchase rates go down, from cereal and soft drinks to lunch meats. Currently, an estimated 11.2 percent of U.S. adults are on GLP-1 medications, but roughly 20 percent could soon be on the medication in just 12 months. "It's one of the fascinating business 'side effects' of medications like Ozempic that grocery stores are seeing a dip in business," Alex Beene, a financial literacy instructor for the University of Tennessee at Martin, told Newsweek. "The idea is these medications suppress hunger, which is causing consumers to purchase food less. And while there is certainly some truth to this, it's too soon to call it a long-term trend. Financially, it can be seen as a good thing for money-strapped customers who can reduce their grocery bills along with their waistlines. Whether or not this economic impact is a lasting one remains to be seen." So far, the medications have triggered grocery volume losses of 1.2 to 2.9 percent, with dollar sales dropping between 0.9 and 2.3 percent, depending on the category, according to the report. GLP-1 users were 65 percent more likely to buy smaller packs of cereal and 48 percent more likely to purchase smaller packs of lunch meats. This extended to soft drinks as well, with those on the medication 36 percent more likely to opt for the smaller sizes. "The opportunity for grocery brands is twofold: A continued migration toward better-for-you products—plus an emphasis on smaller pack sizes—are ways CPG brands can adapt to these changing consumer demands for volume," Rick Miller, partner and marketing effectiveness practice lead at Big Chalk, told Newsweek. What People Are Saying Rick Miller, partner and marketing effectiveness practice lead at Big Chalk, said in a statement: "GLP-1s have crossed the household-penetration threshold where their impact on grocery volumes and dollar sales can no longer be ignored. We're past anecdotes. This is measurable, structural change. Brands and retailers must rethink assortment, pricing, and promotion for a shopper who is literally consuming less." David Navazio, CEO of health care product company Gentell, told Newsweek: "We will see changes in product selection as a result of the changes in people's buying habits, with an emphasis on whole foods, produce, lean meats." For grocery stores, it may take time to adapt. But the change is undoubtedly good for the country as a whole that our population is becoming healthier." Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek: "Like anything else, this comes down to supply and demand. If grocery stores are seeing a drop in volume, the next step would usually be lower prices. That's not what we're seeing. Grocery prices were up another 0.3 percent in June, according to the latest CPI data. So if grocers are losing, I'm not quite sure who's winning yet." Drew Powers, the founder of Illinois-based Powers Financial Group, told Newsweek: "At any given point in time, there is one part of the economy that is booming at the expense of another. This is just the normal oscillation around economic equilibrium. In very general terms, being less obese is healthier, and I think it is a good thing overall to having a healthier population. Grocery stores will slowly adapt to new eating and shopping habits, which will have knockoff effects in other sectors, while some parts of the economy will see increased spending that can be attributed to GLP-1 use." What Happens Next Beyond the economic impacts, the long-term implications of GLP-1 medications on health are still being studied. A recent study discovered a new link between taking GLP-1 drugs and elevated risk of pancreatitis and kidney conditions, including kidney stones. GLP-1 medications are also tied to a higher risk of digestive problems, including nausea, vomiting, diarrhea, and even stomach paralysis in rare cases. For the business economics of grocers reacting to the uptick in GLP-1 usage, prices have not adequately shifted yet, Thompson said. "America has an obesity problem. If these drugs are helping people eat less and live healthier lives, that's a net positive," Thompson said. "But in a capitalist economy—if Adam Smith's invisible hand is really at work—we should be seeing food prices and health care costs fall also. That's not happening. Health care continues to rise at an alarming rate, and food prices are still climbing. Long term, we might expect some price relief, but we're not there yet."
New York Post
4 hours ago
- New York Post
World's tallest hotel in Dubai is set to debut — beating record previously set by the sky-scraping city
What will soon be considered the world's tallest hotel is planned to open later this year as construction nears completion. The Ciel in Dubai will be as luxurious and breathtaking as one would imagine. Once built, it'll reach over 1,197 feet high and have 1,004 rooms, including 147 suites, across 82 floors, according to the hotel's website. The construction of the hotel is in different stages, according to Newsweek. The lobby fit-out is at least 65% complete and parts of the dining areas are 50% done. Meanwhile, the guest room furniture installation is reportedly 45% complete, while the fit-out of the leisure deck is at least 40% done, according to April-May updates shared by the developer. Located in the Dubai Marina, the world's largest human-made one, the Ciel offers guests 360-degree views of the Persian Gulf through floor-to-ceiling glass windows. A rendering of the Ciel in Dubai, the world's tallest hotel. Courtesy The First Group Once completed, the Ciel will dethrone the current tallest hotel in the world, the Gevora Hotel — also in Dubai — which stands at 1,169 feet high. 'Ciel in Dubai Marina is a stunning development that will set a new benchmark as the world's tallest hotel upon completion,' The First Group, the developer of the hotel, said on its website. 'More than an architectural masterpiece, Ciel is a global icon and The First Group's largest and most luxurious project to date.' The hotel will also have the world's highest infinity swimming pool, according to a statement from the China Railway 18th Bureau Group of Dubai (CR18BG), the contractor behind the hotel, to local media, per Newsweek. There will also be a 1,158 feet-high 'sky restaurant,' as well as an 'atrium sky garden' that spans 12 levels. The hotel's infinity pool will live on the 76th floor, at around 1,004 feet in the sky. It forms part of the Tattu Dubai restaurant, bar and lounge complex, which spans three floors. The hotel will also have the world's highest infinity swimming pool. Courtesy The First Group The restaurant will be located on the 74th level, while the Tattu Sky Lounge and Observation Deck will be on the 81st floor, the venue's website said. In total, guests will have 10 different bar and restaurant options throughout the hotel. Additionally, the hotel's communal atrium space will feature 'vertically stacked landscaped and naturally ventilated terraces' at around 984 feet high, The First Group said.
New York Post
5 hours ago
- New York Post
Skip the spa with 33% off the customer-loved TOLOCO Massage Gun on Amazon
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Readers, we could really use a massage. It was a nice weekend and all, but all that [hiking/swimming/partying/walking/pickleball/tennis/squash/fill in the blank with the summer activity of your choosing] left us sore, and we're ready for a massage. Lucky for us (and you, by extension), earlier this year, we spoke to Camila Perez, a licensed massage therapist, esthetician, and certified manual lymphatic drainage therapist, to tap into her 20-plus years of expertise in determining the best massage guns on the market. One such option? The TOLOCO Massage Gun is available for a cool 33% off this week on Amazon. Yes, readers, Prime Day may have technically come and gone, but there are still tons of Prime-Day-worthy Amazon deals popping up every day, and this customer-loved Massage Gun is no exception. This week on Amazon, join over 30,000 other shoppers who've purchased the TOLOCO in just the last month alone, and experience everything a spa has to offer from the comfort of your own home. And you don't just have to take our word for it. Check out one satisfied customer's review below: 'I've been using the TOLOCO Massage Gun for a few weeks now, and I'm really impressed. The different attachments are perfect for targeting various muscle areas, and it's powerful yet quiet. I love that the carry case makes it easy to take on the go, and the build feels solid and durable. Even at the lower settings, it provides a deep massage, which is great for sore muscles after a workout or just relieving everyday tension.' We're sold! Amazon The TOLOCO Massage Gun is a powerful, handheld device designed to relieve muscle soreness and tension. With multiple speed settings and interchangeable heads, it targets various muscle groups effectively. Lightweight and portable, it's perfect for athletes and everyday users alike. Its quiet motor and ergonomic design ensure a comfortable, user-friendly experience, making it ideal for at-home recovery. Best of all? It's available for 33% off today on Amazon. This article was written by P.J. McCormick, New York Post Commerce Deals Writer/Reporter. P.J. is an expert deal-finder, sifting through endless brands and retailers to deliver only the best savings opportunities on truly worthwhile products. P.J. finds Prime Day-worthy deals all year long on some of our favorite products we've tested and our readers' beloved best-sellers, from Wayfair furniture sales to the lowest prices on Apple AirPods. P.J. has been scouring sales for Post Wanted shoppers since 2022 and previously held positions at Rolling Stone, Pitchfork and Hyperallergic. Please note that deals can expire, and all prices are subject to change. Hunting for a headline-worthy haul? Keep shopping with Post Wanted.
